The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 52 results:
Author Title Type [ Year(Asc)]
Filters: Author is Loutradis, Charalampos  [Clear All Filters]
2020
Loutradis, C., Sarafidis P. A., Ferro C. J., & Zoccali C. (2020).  Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management.. Nephrol Dial Transplant.
2019
Sarafidis, P. A., Loutradis C., Karpetas A., Tzanis G., Bikos A., Raptis V., et al. (2019).  The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.. Nephrol Dial Transplant. 34(3), 515-523.
Loutradis, C., Sarafidis P. A., Ekart R., Papadopoulos C., Sachpekidis V., Alexandrou M. Eleni, et al. (2019).  The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial.. Kidney Int. 95(6), 1505-1513.
Piperidou, A., Sarafidis P., Boutou A., Thomopoulos C., Loutradis C., Alexandrou M. Eleni, et al. (2019).  The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(7), 1334-1343.
Piperidou, A., Sarafidis P., Boutou A., Thomopoulos C., Loutradis C., Alexandrou M. Eleni, et al. (2019).  The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus. Journal of Hypertension. 1.
Loutradis, C., Papadopoulou E., Theodorakopoulou M., Karagiannis A., & Sarafidis P. (2019).  The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotection. Future Medicinal Chemistry. 2019 Jun;11(11):1285-1303.
Loutradis, C., Papadopoulou E., Theodorakopoulou M., Karagiannis A., & Sarafidis P. (2019).  The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotection.. Future Med Chem. 11(11), 1285-1303.
Alexandrou, M-E., Papagianni A., Tsapas A., Loutradis C., Boutou A., Piperidou A., et al. (2019).  Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(12), 2307-2324.
Bikos, A., Loutradis C., Angeloudi E., Karpetas A., Raptis V., Kalaitzidis R., et al. (2019).  The effects of nebivolol and irbesartan on postdialysis and ambulatory blood pressure in patients with intradialytic hypertension: a randomized cross-over study.. J Hypertens. 37(2), 432-442.
Theodorakopoulou, M., Raptis V., Loutradis C., & Sarafidis P. (2019).  Hypoxia and Endothelial Dysfunction in Autosomal-Dominant Polycystic Kidney Disease.. Semin Nephrol. 39(6), 599-612.
Stavrinou, E., Sarafidis P. A., Koumaras C., Loutradis C., Giamalis P., Tziomalos K., et al. (2019).  Increased Sclerostin, but Not Dickkopf-1 Protein, Is Associated with Elevated Pulse Wave Velocity in Hemodialysis Subjects.. Kidney Blood Press Res. 44(4), 679-689.
Loutradis, C., Sarafidis P. A., Theodorakopoulou M., Ekart R., Alexandrou M. Eleni, Pyrgidis N., et al. (2019).  Lung Ultrasound-Guided Dry-Weight Reduction in Hemodialysis Patients Does Not Affect Short-Term Blood Pressure Variability.. Am J Hypertens. 32(8), 786-795.
Loutradis, C., Bikos A., Raptis V., Afkou Z., Tzanis G., Pyrgidis N., et al. (2019).  Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension.. Hypertens Res. 42(7), 1001-1010.
Sarafidis, P. A., Mallamaci F., Loutradis C., Ekart R., Torino C., Karpetas A., et al. (2019).  Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.. Nephrol Dial Transplant. 34(9), 1542-1548.
Sarafidis, P. A., Loutradis C., Mayer C. C., Karpetas A., Pagkopoulou E., Bikos A., et al. (2019).  Weak within-individual association of blood pressure and pulse wave velocity in hemodialysis is related to adverse outcomes.. J Hypertens. 37(11), 2200-2208.
2018
Sarafidis, P. A., Ruilope L. M., Loutradis C., Gorostidi M., de la Sierra A., de la Cruz J. J., et al. (2018).  Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients.. J Hypertens. 36(5), 1076-1085.
Bikos, A., Angeloudi E., Memmos E., Loutradis C., Karpetas A., Ginikopoulou E., et al. (2018).  A Comparative Study of Short-Term Blood Pressure Variability in Hemodialysis Patients with and without Intradialytic Hypertension.. Am J Nephrol. 48(4), 295-305.
Loutradis, C., Sarafidis P. A., Papadopoulos C. E., Papagianni A., & Zoccali C. (2018).  The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD.. J Am Soc Nephrol. 29(5), 1372-1381.
Raptis, V., Bakogiannis C., Loutradis C., Boutou A. K., Lampropoulou I., Intzevidou E., et al. (2018).  Levels of Endocan, Angiopoietin-2, and Hypoxia-Inducible Factor-1a in Patients with Autosomal Dominant Polycystic Kidney Disease and Different Levels of Renal Function.. Am J Nephrol. 47(4), 231-238.
Sarafidis, P. A., Mallamaci F., Loutradis C., Ekart R., Torino C., Karpetas A., et al. (2018).  Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.. Nephrol Dial Transplant. 33(10), 1872.
Raptis, V., Loutradis C., & Sarafidis P. A. (2018).  Renal injury progression in autosomal dominant polycystic kidney disease: a look beyond the cysts.. Nephrol Dial Transplant. 33(11), 1887-1895.
Raptis, V., Bakogiannis C., Loutradis C., Boutou A. K., Sioulis A., Balaskas E., et al. (2018).  Serum Fas Ligand, Serum Myostatin and Urine TGF-β1 Are Elevated in Autosomal Dominant Polycystic Kidney Disease Patients with Impaired and Preserved Renal Function.. Kidney Blood Press Res. 43(3), 744-754.
2017
Karpetas, A., Loutradis C., Bikos A., Tzanis G., Koutroumpas G., Lazaridis A. A., et al. (2017).  Blood pressure variability is increasing from the first to the second day of the interdialytic interval in hemodialysis patients.. J Hypertens. 35(12), 2517-2526.
Sarafidis, P. A., Kamperidis V., Loutradis C., Tsilonis K., Mpoutsiouki F., Saratzis A., et al. (2017).  Haemodialysis acutely deteriorates left and right diastolic function and myocardial performance: an effect related to high ultrafiltration volumes?. Nephrol Dial Transplant. 32(8), 1402-1409.
2016
Moschopoulou, M., Ampatzidou F. Ch, Loutradis C., Boutou A., Koutsogiannidis C-P., Drosos G. E., et al. (2016).  Diabetes mellitus does not affect the incidence of acute kidney injury after cardiac surgery; a nested case-control study.. J Nephrol. 29(6), 835-845.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.